Sign in

CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Open-market sale CEO sold 2,409 shares at $3.01 ($7,261)
  2. 4 Open-market sale General Counsel sold 662 shares at $3.01 ($1,995)
  3. 4 Open-market sale See Remarks sold 384 shares at $3.01 ($1,157)
  4. 4 Open-market sale General Counsel sold 3,361 shares at $3.61 ($12,120)
  5. 4 Open-market sale CEO sold 2,728 shares at $3.61 ($9,837)
  6. 4 Open-market sale See Remarks sold 855 shares at $3.61 ($3,083)
  7. 4 Open-market sale See Remarks sold 17,650 shares at $3.84 ($67,741)
  8. 4 Open-market sale See Remarks sold 1,157 shares at $3.34 ($3,862)
  9. 4 Open-market sale CEO sold 5,990 shares at $3.34 ($19,995)
  10. 4 Open-market sale General Counsel sold 1,376 shares at $3.34 ($4,593)
  11. 4 Open-market sale General Counsel sold 12,253 shares at $3.31 ($40,582)
  12. 4 Open-market sale See Remarks sold 3,726 shares at $3.31 ($12,341)
  13. 4 Open-market sale CEO sold 12,279 shares at $3.31 ($40,668)
  14. 4 Grant or award CEO acquired 286,028 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 29,982 shares (grant or award)
  16. 4 Grant or award General Counsel acquired 311,813 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 61,963 shares (grant or award)
  18. 4 Grant or award Chief Operating Officer acquired 61,963 shares (grant or award)
  19. 4 Grant or award See Remarks acquired 125,924 shares (grant or award)
  20. 4 Open-market buy Director bought 10,000 shares at $3.44 ($34,400)

Page 2 of 21 · 406 filings